BioMarin Pharmaceutical Inc. (OQ:BMRN)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
Latest 10 SEC filings (by transaction date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -10,000 $82.52
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $14.39
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $81.97
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $14.39
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $82.16
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $14.39
May 9/19 Apr 30/19 Bienaime Jean Jacques Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 309 $68.78
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -10,000 $82.52
May 14/19 May 10/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $14.39
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $81.97
May 13/19 May 9/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $14.39
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $82.16
May 9/19 May 8/19 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $14.39
May 9/19 Apr 30/19 Bienaime Jean Jacques Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 309 $68.78
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $BMRN

StockTwits